InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Bodmer Mark. Director active across 1 company, notably Evelo Biosciences, Inc.. Cumulatively, 6 filings have been logged. Split: 0 buy · 2 sells. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Bodmer Mark is a declarant linked to Evelo Biosciences, Inc. on XNAS, where he is CSO, President of R&D. He has 6 filings in total, and across the 6 sampled recent filings, the period runs from 2023-05-09 to 2023-11-08, with the dominant transaction nature listed as Levée d'options.